Insider Transactions in Q2 2021 at Recursion Pharmaceuticals, Inc. (RXRX)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 02
2021
|
Shafique Virani Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
45,045
+41.67%
|
$90,090
$2.22 P/Share
|
|
Apr 20
2021
|
Zachary Bogue Director |
BUY
Other acquisition or disposition
|
Indirect |
13,619,224
+50.0%
|
-
|
|
Apr 20
2021
|
Zachary Bogue Director |
SELL
Other acquisition or disposition
|
Indirect |
13,619,224
-100.0%
|
-
|
|
Apr 20
2021
|
Zachary Bogue Director |
BUY
Conversion of derivative security
|
Indirect |
13,619,224
+50.0%
|
-
|
|
Apr 20
2021
|
Terry Ann Burrell Director |
BUY
Conversion of derivative security
|
Direct |
6,250
+4.49%
|
-
|
|
Apr 20
2021
|
Terry Ann Burrell Director |
SELL
Conversion of derivative security
|
Direct |
6,250
-100.0%
|
-
|
|
Apr 20
2021
|
Terry Ann Burrell Director |
BUY
Other acquisition or disposition
|
Direct |
126,561
+50.0%
|
-
|
|
Apr 20
2021
|
Terry Ann Burrell Director |
SELL
Other acquisition or disposition
|
Direct |
126,561
-100.0%
|
-
|
|
Apr 20
2021
|
R. Martin Chavez Director |
BUY
Conversion of derivative security
|
Direct |
6,250
+50.0%
|
-
|
|
Apr 20
2021
|
R. Martin Chavez Director |
SELL
Conversion of derivative security
|
Direct |
6,250
-100.0%
|
-
|
|
Apr 20
2021
|
Data Collective Iv, L.P. > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
13,619,224
+50.0%
|
-
|
|
Apr 20
2021
|
Data Collective Iv, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
13,619,224
-100.0%
|
-
|
|
Apr 20
2021
|
Data Collective Iv, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
13,619,224
+50.0%
|
-
|
|
Apr 20
2021
|
Blake Borgeson Director |
BUY
Conversion of derivative security
|
Direct |
7,688,356
+50.0%
|
-
|
|
Apr 20
2021
|
Blake Borgeson Director |
SELL
Conversion of derivative security
|
Direct |
7,688,356
-100.0%
|
-
|
|
Apr 20
2021
|
Blake Borgeson Director |
BUY
Conversion of derivative security
|
Direct |
923,052
+10.72%
|
-
|
|
Apr 20
2021
|
Christopher Gibson Chief Executive Officer |
BUY
Other acquisition or disposition
|
Indirect |
150,000
+50.0%
|
-
|
|
Apr 20
2021
|
Christopher Gibson Chief Executive Officer |
SELL
Other acquisition or disposition
|
Indirect |
150,000
-100.0%
|
-
|
|
Apr 20
2021
|
Christopher Gibson Chief Executive Officer |
BUY
Other acquisition or disposition
|
Direct |
9,317,883
+50.0%
|
-
|
|
Apr 20
2021
|
Christopher Gibson Chief Executive Officer |
SELL
Other acquisition or disposition
|
Direct |
9,317,883
-100.0%
|
-
|
|
Apr 20
2021
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
55,383
+0.59%
|
-
|
|
Apr 20
2021
|
Robert Hershberg Director |
BUY
Conversion of derivative security
|
Direct |
6,250
+50.0%
|
-
|
|
Apr 20
2021
|
Robert Hershberg Director |
SELL
Conversion of derivative security
|
Direct |
6,250
-100.0%
|
-
|
|
Apr 20
2021
|
Tina Marriott Larson President and COO |
BUY
Other acquisition or disposition
|
Direct |
52,500
+50.0%
|
-
|
|
Apr 20
2021
|
Tina Marriott Larson President and COO |
SELL
Other acquisition or disposition
|
Direct |
52,500
-100.0%
|
-
|
|
Apr 20
2021
|
Dean Y Li Director |
BUY
Other acquisition or disposition
|
Direct |
596,390
+26.14%
|
-
|
|
Apr 20
2021
|
Dean Y Li Director |
SELL
Other acquisition or disposition
|
Direct |
596,390
-100.0%
|
-
|
|
Apr 20
2021
|
Dean Y Li Director |
BUY
Other acquisition or disposition
|
Indirect |
3,222,048
+50.0%
|
-
|
|
Apr 20
2021
|
Dean Y Li Director |
SELL
Other acquisition or disposition
|
Indirect |
3,222,048
-100.0%
|
-
|
|
Apr 20
2021
|
Dean Y Li Director |
BUY
Conversion of derivative security
|
Indirect |
55,383
+3.75%
|
-
|
|
Apr 20
2021
|
Michael Secora Chief Financial Officer |
BUY
Other acquisition or disposition
|
Direct |
528,762
+50.0%
|
-
|
|
Apr 20
2021
|
Michael Secora Chief Financial Officer |
SELL
Other acquisition or disposition
|
Direct |
528,762
-100.0%
|
-
|
|
Apr 20
2021
|
Michael Secora Chief Financial Officer |
BUY
Conversion of derivative security
|
Direct |
149,077
+21.99%
|
-
|
|
Apr 20
2021
|
Shafique Virani Chief Business Officer |
BUY
Other acquisition or disposition
|
Direct |
18,000
+50.0%
|
-
|
|
Apr 20
2021
|
Shafique Virani Chief Business Officer |
SELL
Other acquisition or disposition
|
Direct |
18,000
-100.0%
|
-
|
|
Apr 20
2021
|
Investment CO Pjsc Mubadala > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
13,026,009
+32.59%
|
-
|
|
Apr 20
2021
|
Lux Ventures Iv, L.P. |
BUY
Conversion of derivative security
|
Indirect |
17,187,095
+49.86%
|
-
|
|
Apr 20
2021
|
Lux Ventures Iv, L.P. |
SELL
Conversion of derivative security
|
Indirect |
17,187,095
-100.0%
|
-
|
|
Apr 20
2021
|
Lux Ventures Iv, L.P. |
BUY
Conversion of derivative security
|
Indirect |
17,174,594
+49.98%
|
-
|
|
Apr 16
2021
|
Investment CO Pjsc Mubadala > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
2,777,777
+50.0%
|
$49,999,986
$18.0 P/Share
|
|
Apr 16
2021
|
Lux Ventures Iv, L.P. |
BUY
Open market or private purchase
|
Indirect |
100,000
+50.0%
|
$1,800,000
$18.0 P/Share
|
|
Apr 16
2021
|
Blake Borgeson Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,250
+0.09%
|
-
|
|
Apr 16
2021
|
Terry Ann Burrell Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,250
+4.71%
|
-
|
|
Apr 16
2021
|
R. Martin Chavez Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,250
+50.0%
|
-
|
|
Apr 16
2021
|
Robert Hershberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,250
+50.0%
|
-
|
|
Apr 16
2021
|
Dean Y Li Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,889
+2.28%
|
-
|